Wellington Management Group LLP Gritstone Bio, Inc. Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $648,914 - $960,129	331,079 New	331,079 $850,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.74 $327,951 - $575,840	153,968 New	153,968 $428,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $357 - $876	-202 Reduced 0.09%	236,678 $573,000
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $159,749 - $483,211	39,640 Added 20.1%	236,880 $976,000
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $1.73 Million - $2.7 Million	197,240 New	197,240 $2.54 Million
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $6.33 Million - $13.4 Million	-987,617 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $219,005 - $274,767	-26,938 Reduced 2.66%	987,617 $9.02 Million
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $4.13 Million - $27.5 Million	1,014,555 New	1,014,555 $9.57 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.